Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Nov 9, 2015

Andrew Saunders (CMO of Lytix Biopharma) presented LTX-315 at THIRD MELANOMA MIB CONFERENCE in Rome November 9th.

See program